Clinical Research Directory
Browse clinical research sites, groups, and studies.
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes
Sponsor: Umraniye Education and Research Hospital
Summary
Investigation of the relationship between maternal serum vasohibin-1, vasohibin-2, cardiotrophin -1 and endocan concentrations at the 11th and 14th weeks of gestation and adverse perinatal outcomes.
Official title: Investigation of First Trimester Serum Vasohibin-1, Vasohibin-2, Cardiotrophin-1 and Endocan Concentrations in Predicting Adverse Perinatal Outcomes
Key Details
Gender
FEMALE
Age Range
18 Years - 39 Years
Study Type
OBSERVATIONAL
Enrollment
88
Start Date
2023-03-03
Completion Date
2024-12-30
Last Updated
2024-05-16
Healthy Volunteers
Not specified
Conditions
Interventions
first trimester serum diagnostic test
First trimester serum vasohibin-1, vasohibin-2, cardiotropin-1 and endocan concentrations predict adverse perinatal outcomes
Locations (1)
Ümraniye Eğitim ve Araştırma Hastanesi
Istanbul, Ümraniye, Turkey (Türkiye)